Pages

▼
Friday, April 17, 2026

The Hidden Pitfalls of Hub Transitions—and How to Navigate Them

›
Today’s guest post comes from Brok Vandersteen, Vice President of Business Development at AssistRx. Brok explains how missteps during pat...
Tuesday, April 14, 2026

Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update

›
By Adam J. Fein, Ph.D. It's time for Drug Channels Institute’s (DCI) annual update of vertical integration among insurers, PBMs, special...
Monday, April 13, 2026

Informa Connect’s Life Sciences Pricing & Contracting USA

›
Informa Connect’s Life Sciences Pricing & Contracting USA May 18-20, 2026 | Philadelphia, PA Drug Channels readers save 10% with co...
Friday, April 10, 2026

The Net Pricing Revolution in the Drug Channel: What’s Deflating the Gross-to-Net Bubble (rerun)

›
This week, I’m rerunning some popular posts while we prepare for today’s live video webinar: PBM Industry Update 2026: Trends, Challenges, a...
Thursday, April 09, 2026

The FTC Blows Up Express Scripts’ PBM Model—and Launches the Net Pricing Drug Channel (rerun)

›
This week, I’m rerunning some popular posts while we prepare for tomorrow’s live video webinar: PBM Industry Update 2026: Trends, Challenges...
Wednesday, April 08, 2026

List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)

›
This week, I’m rerunning some popular posts while we prepare for Friday’s live video webinar: PBM Industry Update 2026: Trends, Challenges, ...
Tuesday, April 07, 2026

Drug Channels News Roundup, Mid-April 2026: Vertical Integration & MLR Games, Copay Maximizers, Hospital Price Chaos, and One Big Drug Channel Family

›
I’m pleased to introduce a new recurring feature from Bryce Platt , DCI’s new Director. Each month, Bryce will highlight some of his most no...
Monday, April 06, 2026

The Big Three PBMs’ 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct-to-Patient Threats for PBMs (rerun)

›
This week, we're rerunning some popular posts while we prepare for Friday’s live video webinar: PBM Industry Update 2026: Trends, Challe...
Thursday, April 02, 2026

Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26

›
Today’s guest post comes from Chrissy Hand, Chief Product and Commercial Officer at CoverMyMeds. Chrissy highlights key themes in the fut...
Tuesday, March 31, 2026

Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo

›
By Adam J. Fein, Ph.D. Spring is here in always-sunny Philadelphia. The vernal equinox has brought us an unexpected bounty of noteworthy new...
Monday, March 30, 2026

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments

›
By Adam J. Fein, Ph.D. Three is still the magic number for pharmacy benefit managers (PBMs). For 2025, 80% of all equivalent prescription c...
Friday, March 27, 2026

The Rare Journey Needs a Special Pharmacy Partner

›
Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare. Bansi argues that rare disease pharmacy is a fundamenta...